Lenox Wealth Management Inc. grew its holdings in HCP, Inc. (NYSE:HCP) by 2,026.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,763 shares of the real estate investment trust’s stock after buying an additional 7,398 shares during the quarter. Lenox Wealth Management Inc.’s holdings in HCP were worth $276,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Quest Capital Management Inc. ADV acquired a new stake in shares of HCP in the 3rd quarter valued at approximately $28,000. Westside Investment Management Inc. acquired a new stake in shares of HCP in the 2nd quarter valued at approximately $31,000. Bartlett & Co. LLC acquired a new stake in shares of HCP in the 3rd quarter valued at approximately $36,000. NEXT Financial Group Inc lifted its holdings in shares of HCP by 181.3% in the 2nd quarter. NEXT Financial Group Inc now owns 1,125 shares of the real estate investment trust’s stock valued at $36,000 after buying an additional 725 shares during the period. Finally, CSat Investment Advisory L.P. lifted its holdings in shares of HCP by 77.6% in the 2nd quarter. CSat Investment Advisory L.P. now owns 1,165 shares of the real estate investment trust’s stock valued at $37,000 after buying an additional 509 shares during the period. 95.80% of the stock is owned by institutional investors and hedge funds.
In other news, COO Thomas Klaritch sold 35,014 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $36.02, for a total value of $1,261,204.28. Following the completion of the transaction, the chief operating officer now directly owns 230,529 shares of the company’s stock, valued at $8,303,654.58. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.13% of the company’s stock.
Several analysts have recently commented on HCP shares. ValuEngine cut HCP from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Zacks Investment Research raised HCP from a “hold” rating to a “buy” rating and set a $39.00 price target for the company in a report on Monday, October 14th. JPMorgan Chase & Co. raised HCP from a “neutral” rating to an “overweight” rating and raised their price target for the company from $35.00 to $38.00 in a report on Tuesday, October 8th. KeyCorp lifted their price objective on HCP from $34.00 to $37.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Finally, Stifel Nicolaus lifted their price objective on HCP from $34.00 to $37.00 and gave the stock a “buy” rating in a report on Tuesday, September 3rd. They noted that the move was a valuation call. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. HCP has a consensus rating of “Buy” and a consensus price target of $36.78.
HCP stock traded down $0.89 during midday trading on Friday, hitting $33.64. 4,003,528 shares of the stock were exchanged, compared to its average volume of 2,801,829. The stock’s 50-day moving average price is $36.24 and its 200-day moving average price is $33.42. The stock has a market cap of $17.57 billion, a price-to-earnings ratio of 18.48, a PEG ratio of 6.81 and a beta of 0.22. HCP, Inc. has a fifty-two week low of $26.58 and a fifty-two week high of $37.93. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.81 and a current ratio of 0.81.
HCP (NYSE:HCP) last issued its quarterly earnings data on Wednesday, October 30th. The real estate investment trust reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($0.52). HCP had a return on equity of 12.78% and a net margin of 43.66%. The firm had revenue of $538.00 million for the quarter, compared to analyst estimates of $503.65 million. During the same period in the prior year, the firm posted $0.44 earnings per share. The business’s revenue for the quarter was up 18.0% compared to the same quarter last year. Research analysts anticipate that HCP, Inc. will post 1.75 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be issued a $0.37 dividend. The ex-dividend date of this dividend is Friday, November 1st. This represents a $1.48 dividend on an annualized basis and a dividend yield of 4.40%. HCP’s dividend payout ratio (DPR) is 81.32%.
HCP Company Profile
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Story: Understanding Price to Earnings Ratio (PE)
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.